With the ever-increasing pace at which the healthcare landscape is evolving, digital tools are playing a bigger role in the enrollment for and selection of plans in Medicare. Phone consultations and traditional brochures are slowly being relegated as technology takes center stage. We explore how tech tools are helping qualifying individuals to enroll for and select appropriate coverage plans under Medicare.
The Plan Finder at Medicare.gov
This tool helps beneficiaries in their bid to compare different MA plans and the prescription drug plans available under Part D. A user is required to input their prescription medications, the doctors they prefer and any other health considerations they may have.
The tool will then generate different available plans together with their copays, premiums, and the costs that one will incur out-of-pocket.
With this tool, you can check whether your preferred doctors are within or outside your preferred network, compare the projected annual medical costs, view the ratings of a given plan and access the coverage details.
It should be noted that private insurance firms often provide mobile apps that you can use to manage your health plan. The features of each app can vary but they often include a feature to let you view the benefits you qualify for, schedule appointments with your doctor and also check the status of your claim.
Virtual Consulting Services
Nonprofits and private entities also facilitate users to have online consultations through live chats and virtual meetings. Generally, such services specialize in supporting users to manage their benefits or guide them in plan selection.
Online Enrollment Options
Many mobile apps and platforms of insurance providers have capabilities geared at helping people enroll for Medicare Advantage. Their systems can submit your application electronically and give you notifications about deadlines.
If you choose to use a third-party tool to compare policies, take the added step of verifying that the information on available plans is accurate and complete. The websites of insurance firms, insurance agents licensed by Medicare authorities and counselors assisting with state health insurance programs can also be of help.
As digital tools become more prominent, it is critical that the digital divide between those who are tech savvy and those who aren’t very comfortable or knowledgeable in the use of these tools is bridged. Workshops, educational sessions, and personal assistance to these seniors can help to overcome many of the barriers standing in the way of universal adoption of digital solutions. Such one-on-one help can go a long way towards making seniors trust virtual tools while also cutting the costs of providers. Firms like Astiva Health that provide MA coverage can come up with innovative ways to bring on board those who are reluctant to use digital tools.
NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
In the United States alone, close to one million people are living with MS, with…
A nationwide survey conducted by the Commonwealth Fund has found that contrary to a common…
Earth Science Tech has uplisted to the OTCQB Venture Market, a premier public market that…
VERAXA is advancing an oncology pipeline centered on its proprietary BiTAC(R) platform, alongside additional antibody-drug…
A new study has found that the risk of people developing sepsis, meningitis or pneumonia…
Scientists have been struggling to understand why more people who are less than 55 years…